| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/10/2002 | CA2414995A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 01/10/2002 | CA2414873A1 Method for the analysis of a selected multicomponent sample |
| 01/10/2002 | CA2414672A1 Novel human serine-threonine kinase |
| 01/10/2002 | CA2414650A1 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 01/10/2002 | CA2414626A1 A method for extracting quantitative information relating to interactions between cellular components |
| 01/10/2002 | CA2414596A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | CA2414594A1 Process for the measurement of dinophysistoxin and of yessotoxin |
| 01/10/2002 | CA2414590A1 Methods for monitoring treatment of helicobacter infection and for predicting the likelihood of successful eradication |
| 01/10/2002 | CA2414497A1 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 01/10/2002 | CA2414375A1 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 01/10/2002 | CA2413753A1 Antifungal compounds and methods of use |
| 01/10/2002 | CA2413262A1 B7-like molecules and uses thereof |
| 01/10/2002 | CA2413186A1 Extracellular matrix and cell adhesion molecules |
| 01/10/2002 | CA2413158A1 Ecm-related tumor marker |
| 01/10/2002 | CA2413128A1 Transporters and ion channels |
| 01/10/2002 | CA2412973A1 Sequencing method and apparatus |
| 01/10/2002 | CA2412946A1 Method for controlling the microbiological quality of an aqueous medium and kit therefor |
| 01/10/2002 | CA2412925A1 A novel app mutation associated with an unusual alzheimer's disease pathology |
| 01/10/2002 | CA2412872A1 Protein modification and maintenance molecules |
| 01/10/2002 | CA2412292A1 Base analogues |
| 01/10/2002 | CA2411794A1 Signal amplification with lollipop probes |
| 01/10/2002 | CA2411692A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | CA2410953A1 Adenylyl and guanylyl cyclases |
| 01/10/2002 | CA2410679A1 Secretion and trafficking molecules |
| 01/10/2002 | CA2408829A1 Regulated gene expression in yeast and methods of use |
| 01/10/2002 | CA2407910A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | CA2406649A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/09/2002 | EP1170710A1 Safety device for combustible gases or liquids |
| 01/09/2002 | EP1170594A2 Methods for the identification of compounds useful for the treatment of disease states mediated by Prostaglandin D2 |
| 01/09/2002 | EP1170593A2 Reagent, kit and method for the determination of total proteins and globulines such as hemoglobin in biological fluids |
| 01/09/2002 | EP1170592A1 Presentation of hydrophobic antigens to T-cells by CD1 molecules |
| 01/09/2002 | EP1170591A2 Methods for identifying combinations of entities as therapeutics |
| 01/09/2002 | EP1170590A1 Control solution containing an adsorbent |
| 01/09/2002 | EP1170589A1 Method for histocompatibility testing |
| 01/09/2002 | EP1170588A1 A method of testing the purity or stability of 'lamotrigine' with the use of a 1,2,4-triazine derivative as reference marker |
| 01/09/2002 | EP1170585A1 Water-based water treatment method |
| 01/09/2002 | EP1170581A2 Apparatus and method for the automatic measurement of the ripening degree of vegetable products |
| 01/09/2002 | EP1170383A2 Oligonucleotides and method for detection of small round structured virus (SRSV) RNA |
| 01/09/2002 | EP1170380A2 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 01/09/2002 | EP1170377A2 Method for identifying inhibitors of protoporphyrinogen oxidase |
| 01/09/2002 | EP1170057A2 Apparatus and method for preparative supercritical fluid chromatography |
| 01/09/2002 | EP1170016A2 Urease-based vaccine against helicobacter infection |
| 01/09/2002 | EP1170008A1 Valproic acid and derivatives thereof as histone deacetylase inhibitors |
| 01/09/2002 | EP1169649A2 Microarrays of polypeptides |
| 01/09/2002 | EP1169648A1 Use of 13c-nmr to detect binding |
| 01/09/2002 | EP1169647A1 Method for analyzing the amount of intraabdominal adipose tissue |
| 01/09/2002 | EP1169646A2 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases |
| 01/09/2002 | EP1169645A2 Methods and compositions for diagnosing carcinomas |
| 01/09/2002 | EP1169644A1 Method to type prion proteins |
| 01/09/2002 | EP1169643A2 Quality control for cytochemical assays |
| 01/09/2002 | EP1169642A1 Complex formed by n-linked glycoproteins (siblings) and factor h |
| 01/09/2002 | EP1169641A1 Proteome mining |
| 01/09/2002 | EP1169640A2 Method for detecting conditions by analysis of aqueous condensate from respiratory gases |
| 01/09/2002 | EP1169639A1 Method and device for controlling a vat containing oil or cooking fat in situ |
| 01/09/2002 | EP1169638A1 Methods for optimal usage and improved valuation of corrosive petroleum feedstocks and fractions |
| 01/09/2002 | EP1169632A1 Optical autofocus for use with microtiter plates |
| 01/09/2002 | EP1169514A1 Correction of measurements with sensors affected by several properties of a material |
| 01/09/2002 | EP1169479A2 Methods for detecting nucleic acids indicative of cancer |
| 01/09/2002 | EP1169478A2 Method for identifying organisms by means of comparative genetic analysis and primers and hybridisation probes for carrying out this method |
| 01/09/2002 | EP1169477A1 ISOLATION OF cDNA ENCODING FOR SECRETED OR MEMBRANAL PROTEINS |
| 01/09/2002 | EP1169476A1 Detection of melanoma |
| 01/09/2002 | EP1169475A1 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy |
| 01/09/2002 | EP1169473A1 High sensitivity phage display biomolecule detection |
| 01/09/2002 | EP1169472A2 Compound assay using nematodes |
| 01/09/2002 | EP1169471A2 Method for screening compounds using nematode worms |
| 01/09/2002 | EP1169469A1 Human colon cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1169459A1 Dsp-9 dual-specificity map kinase phosphatase |
| 01/09/2002 | EP1169455A1 Compounds and methods for the diagnosis and treatment of babesia microti infection |
| 01/09/2002 | EP1169453A1 Inhibition of viral infection using monovalent antigen-binding proteins |
| 01/09/2002 | EP1169451A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
| 01/09/2002 | EP1169447A1 Genes and expression products from hematopoietic cells |
| 01/09/2002 | EP1169446A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 01/09/2002 | EP1169445A2 Human proteins and polynucleotides encoding them |
| 01/09/2002 | EP1169444A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 01/09/2002 | EP1169443A1 REAGENTS AND METHODS FOR IDENTIFYING AND MODULATING EXPRESSION OF GENES REGULATED BY p21 |
| 01/09/2002 | EP1169440A1 48 human secreted proteins |
| 01/09/2002 | EP1169437A1 Noninvasive detection of colorectal cancer and other gastrointestinal pathology |
| 01/09/2002 | EP1169363A1 Isobutene polymerisation process |
| 01/09/2002 | EP1169348A1 Purposeful movement of human migratory cells away from an agent source |
| 01/09/2002 | EP1169347A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/09/2002 | EP1169346A1 48 human secreted proteins |
| 01/09/2002 | EP1169345A2 Genes associated with diseases of the kidney |
| 01/09/2002 | EP1169343A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 01/09/2002 | EP1169342A2 Tuberculosis antigens and methods of use therefor |
| 01/09/2002 | EP1169334A1 48 human secreted proteins |
| 01/09/2002 | EP1169333A1 49 human secreted proteins |
| 01/09/2002 | EP1169123A1 Encoding scheme for solid phase chemical libraries |
| 01/09/2002 | EP1169066A1 A novel method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 01/09/2002 | EP1169064A2 Method of detecting endometriosis |
| 01/09/2002 | EP1169058A1 Insulin-like growth factor binding protein-4 protease |
| 01/09/2002 | EP1169057A2 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 01/09/2002 | EP1169054A2 Products and methods for treating ptp lar related diseases |
| 01/09/2002 | EP1169049A2 Treatment of myeloma bone disease with proteasomal and nf-kappa-b activity inhibitors |
| 01/09/2002 | EP1169047A1 Compositions and methods for treatment of diabetes |
| 01/09/2002 | EP1169036A2 Anti-viral uses of leflunomide products |
| 01/09/2002 | EP1168962A1 Assessment of psychiatric and neurological conditions |
| 01/09/2002 | EP1168917A2 Human lung cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1086363B1 Automatic analysis apparatus used for timing blood coagulation |
| 01/09/2002 | EP1076568A4 Non-invasive methods to detect prostate cancer |
| 01/09/2002 | EP1068513B1 Improvements in and relating to biomedical assays |